Les responsables politiques américains à la recherche d'un plan B
- The impact on US activity of states delaying reopening or re-imposing restrictions is starting to show in some real-time data
- Discussions on a fiscal stimulus still focus on propping up household income now. This is a very costly and not necessarily very efficient. On the monetary policy side, the Fed seems to be thinking hard about “yield control”
The re-acceleration of the covid epidemic in the US is a month-old now, but last week for the first time some real-time data reflected a relapse in activity. This is still very mild and nowhere near the collapse seen in March and April, but in GDP weighted-terms 60% of the states have delayed their re-opening or rolled-back some relaxation of the containment measures. It is starting to show.
For several weeks we have been discussing this in combination with the speed and size of an additional policy stimulus. Indeed, financial markets seem ready to take some delay in the normalization of the largest economy of the world in their stride as long as more fiscal spending can promise a swifter rebound later. We need to look at the quality of the stimulus under discussion though.
The Democrats’ HEROES Act worth USD 3tn (8% of GDP in 2020 and 6.7% next year) is ready and approved by the House. It seemed it was “dead on arrival” given the opposition of the Republicans in the Senate. However, last week President Trump said he could increase a second unconditional cash handout – HEROES’ flagship measure – beyond what the Democrats proposed. We find the focus on household income quite puzzling. Indeed, the first stimulus is so large that in May income was already 3.8% higher than before the pandemic. The logic might be to pump up so much pent-up demand that consumption would recover faster than expected once restrictions are lifted. A drawback however is that if the reopening is delayed, the government will have spent trillions for very limited macroeconomic gain.
The Fed is thinking hard about a “plan B” if the economy fails to recover as quickly as hoped. The latest minutes suggest a lot of interest for yield control. We think it might be well suited to a central bank reluctant to engage in negative rate policy, while traditional QE may not be very efficient if the pre-set quantum of purchases is constantly dwarfed by even more sovereign issuance than expected. Through Philip Lane the ECB expressed its reluctance to contemplate this option. The ECB’s “limits” may have struck again, even if for now the ECB is enjoying a rare respite, with good news on the European front of the pandemic and on the German Constitutional Court.
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.
This document has been edited by AXA INVESTMENT MANAGERS SA, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 393 051 826. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.
In the UK, this document is intended exclusively for professional investors, as defined in Annex II to the Markets in Financial Instruments Directive 2014/65/EU (“MiFID”). Circulation must be restricted accordingly.
© AXA Investment Managers 2020. All rights reserved